MenQuadfi™ (meningococcal [Groups A, C, Y, W] conjugate vaccine) – New drug approval
April 24, 2020 - Sanofi announced the FDA approval of MenQuadfi (meningococcal [Groups A, C, Y, W] conjugate vaccine), for active immunization for the prevention of invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, W, and Y.
Top